Sign in
Taking people in United StatesNo phase

Tracking thinking skills and brain scans in people getting radiation for brain tumors

Follows adults with brain tumors having radiation, checking thinking tests and brain scans.

Key facts

Who runs it
Jona Hattangadi-Gluth
Where
San Diego, United StatesSee the site
Trial code
Registry title
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
Status
Recruiting
People taking part
300 people, planned
Started
Jan 2015
Expected to end
Dec 2030
Type of study
Observational
Record updated
10 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a primary brain tumor who will have radiation therapy to part of the brain, given in several sessions. It studies thinking and memory changes and brain scans over time.

Age
18 Years to 99 Years
Sex
All
Disease stage
Primary brain tumor (a tumor that started in the brain), such as glioma, meningioma or schwannoma. Karnofsky performance status (KPS) ≥70, a measure of how well you manage daily life. Life expectancy of ≥1 year.
Earlier treatment
People who had radiation therapy to the brain before cannot join. People must be planned to receive fractionated partial brain radiation therapy.

Main reasons for not taking part

  • Not able to have an MRI scan with contrast dye
  • Earlier radiation therapy to the brain
  • Not able to complete thinking and memory tests

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients 18 years or older
  • Karnofsky performance status (KPS) ≥70
  • Life expectancy of ≥1 year
  • Primary brain tumor patients who will receive fractionated partial brain RT
  • Able to complete neurocognitive assessments

Who cannot take part

  • Prior brain RT
  • Inability to undergo MRI with contrast

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Where in United States

  • Moores Cancer CenterSan Diego, United StatesContact: Lara J RoseTaking people

About the trial

What the trial wants to find out

In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will be acquired through this study to improve understanding of cognitive changes associated with radiation dosage to non-targeted tissue, and will provide the basis for evidence-based cognitive- sparing brain radiotherapy.

The group in the trial

  • Primary brain tumour patients receiving RT

    Primary brain tumor patients are screened at time of consultation for this observational study, and the study population is diverse across sex/gender, and racial/ethnic groups.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy
Plain-language title
Tracking thinking skills and brain scans in people getting radiation for brain tumorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05576103, who can take part
Record updated
10 June 2026